Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Total Debt: 2021-2024

Historic Total Debt for Legend Biotech (LEGN) over the last 4 years, with Dec 2024 value amounting to $301.2 million.

  • Legend Biotech's Total Debt fell 51.83% to $142.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.9 million, marking a year-over-year decrease of 51.83%. This contributed to the annual value of $301.2 million for FY2024, which is 7.06% up from last year.
  • As of FY2024, Legend Biotech's Total Debt stood at $301.2 million, which was up 7.06% from $281.3 million recorded in FY2023.
  • Over the past 5 years, Legend Biotech's Total Debt peaked at $301.2 million during FY2024, and registered a low of $120.5 million during FY2021.
  • Its 3-year average for Total Debt is $281.2 million, with a median of $281.3 million in 2023.
  • Data for Legend Biotech's Total Debt shows a peak YoY soared of 116.61% (in 2022) over the last 5 years.
  • Over the past 4 years, Legend Biotech's Total Debt (Yearly) stood at $120.5 million in 2021, then spiked by 116.61% to $260.9 million in 2022, then increased by 7.82% to $281.3 million in 2023, then climbed by 7.06% to $301.2 million in 2024.